Anti-IIa and anti-Xa plasma activities after subcutaneous low-dose application of low-molecular-weight heparins to rabbits. 1988

G Harbauer, and P Kettenring
Department of Experimental Surgery, Saar University, Homburg/Saar, FRG.

Low-molecular-weight heparin (LMWH) derivatives differ among one another and from unfractioned heparin (UFH) in their half-life as well as in their mode of action. Our aim was to find out, whether the plasma activity levels and their time course after subcutaneous low-dose application of LMWH or UFH in the experimental rabbit are comparable to those in humans. Fairly reasonable standard curves for each LMWH preparation were obtained by using geometrical dilution series of spiked rabbit pool plasma and by applying the methods of Bartl et al. (anti-IIa) and Holmer et al. (anti-Xa). The latter method was slightly modified in order to achieve discernable photometric absorptions for activity levels less than 0.05 U/ml. Rabbits under intravenous general anesthesia received an anterior neck incision. The right external jugular vein was dissected free. A catheter was inserted, advanced into the upper caval vein and kept patent by continuous infusion of 10 ml/h of normal saline. Blood samples of 4 ml were collected in syringes containing 1 ml sodium citrate, before and 1, 2, 4 and 8 h after subcutaneous injection of a LMWH derivative or UFH. The samples were centrifuged and frozen to -30 degrees C. For the estimation of heparin-like anti-IIa and anti-Xa activities the samples were thawed and treated in the same manner as the samples from which the standard curves had been derived.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D011516 Prothrombin A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia. Coagulation Factor II,Factor II,Blood Coagulation Factor II,Differentiation Reversal Factor,Factor II, Coagulation,Factor, Differentiation Reversal,II, Coagulation Factor
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D006495 Heparin, Low-Molecular-Weight Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism. LMWH,Low-Molecular-Weight Heparin,Low Molecular Weight Heparin,Heparin, Low Molecular Weight
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015842 Serine Proteinase Inhibitors Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. Serine Endopeptidase Inhibitor,Serine Endopeptidase Inhibitors,Serine Protease Inhibitor,Serine Protease Inhibitors,Serine Proteinase Antagonist,Serine Proteinase Antagonists,Serine Proteinase Inhibitor,Serine Proteinase Inhibitors, Endogenous,Serine Proteinase Inhibitors, Exogenous,Serine Protease Inhibitors, Endogenous,Serine Protease Inhibitors, Exogenous,Antagonist, Serine Proteinase,Endopeptidase Inhibitor, Serine,Inhibitor, Serine Endopeptidase,Inhibitor, Serine Protease,Inhibitor, Serine Proteinase,Protease Inhibitor, Serine,Proteinase Antagonist, Serine,Proteinase Inhibitor, Serine
D015951 Factor Xa Activated form of factor X that participates in both the intrinsic and extrinsic pathways of blood coagulation. It catalyzes the conversion of prothrombin to thrombin in conjunction with other cofactors. Autoprothrombin C,Coagulation Factor Xa,Factor X, Activated,Thrombokinase,Activated Factor X,Blood Coagulation Factor X, Activated,Factor 10A,Factor Ten A,Factor Xa, Coagulation

Related Publications

G Harbauer, and P Kettenring
October 2009, Journal of controlled release : official journal of the Controlled Release Society,
G Harbauer, and P Kettenring
September 2010, Clinical pharmacokinetics,
G Harbauer, and P Kettenring
August 1990, The Journal of laboratory and clinical medicine,
G Harbauer, and P Kettenring
November 2010, Clinical pharmacokinetics,
G Harbauer, and P Kettenring
May 1986, Thrombosis research,
Copied contents to your clipboard!